e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
ME9 Genetic testing and counselling of patients with rare interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic testing and counselling of patients with rare ILDs
R. Borie (Paris, France)
Source:
International Congress 2019 – ME9 Genetic testing and counselling of patients with rare interstitial lung diseases
Session:
ME9 Genetic testing and counselling of patients with rare interstitial lung diseases
Session type:
Meet the expert
Number:
4851
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Borie (Paris, France). Genetic testing and counselling of patients with rare ILDs. International Congress 2019 – ME9 Genetic testing and counselling of patients with rare interstitial lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Genetic counselling
Source: Eur Respir Monogr 2019; 85: 143-149
Year: 2019
Impact of pre-test voluntary counseling on notification of HIV-infection in patients with tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005
Genetic studies in paediatric interstitial lung disease
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Genetic counselling in a national referral centre for pulmonary hypertension
Source: Eur Respir J 2016; 47: 541-552
Year: 2016
Exercise testing in interstitial lung disease diagnosis and management
Source: Eur Respir Mon; 2009: 46: 7
Year: 2009
Aetiological testing in patients with bronchiectasis
Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Year: 2014
Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution
Source: Eur Respir J 2012; 39: 1292-1293
Year: 2012
Genetic and non-genetic risk factors for severe pulmonary sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020
Dietary counselling in patients with advanced pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 552s
Year: 2003
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis
Source: Eur Respir J, 49 (5) 1602314; 10.1183/13993003.02314-2016
Year: 2017
Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021
Genetic typing of bronchial asthma afflicted people according to polymorphous genes for the purpose of disease progress risk factors detection
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances?
Source: Eur Respir J 2016; 47: 388-389
Year: 2016
Genetic risk for covid-19 outcomes in COPD
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Early diagnosis of COPD in a high-risk population using spirometric screening in general practice
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept